UBS Group’s Nu Skin NUS Stock Holding History

UBS Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,600	Closed	-$172K	–	8064
2019 Q1	$172K	Buy	+3,600	New	+$218K	﹤0.01%	4710
2017 Q4	–	Sell	-40,000	Closed	-$2.46M	–	8012
2017 Q3	$2.46M	Sell	40,000 -40,000	-50%	-$2.46M	﹤0.01%	2942
2017 Q2	$5.03M	Hold	80,000	–	–	﹤0.01%	2146
2017 Q1	$4.44M	Buy	80,000 +40,000	+100%	+$2.06M	﹤0.01%	2184
2016 Q4	$1.91M	Hold	40,000	–	–	﹤0.01%	2951
2016 Q3	$2.59M	Buy	+40,000	New	+$2.25M	﹤0.01%	2612
2016 Q1	–	Sell	-200	Closed	-$8K	–	7999
2015 Q4	$8K	Hold	200	–	–	﹤0.01%	7432
2015 Q3	$8K	Hold	200	–	–	﹤0.01%	7411
2015 Q2	$9K	Sell	200 -200,000	-100%	-$10.8M	﹤0.01%	7541
2015 Q1	$12.1M	Buy	200,200 +145,000	+263%	+$7.38M	0.01%	1326
2014 Q4	$2.41M	Buy	+55,200	New	+$2.44M	﹤0.01%	2718

Other funds holding NUS

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group's NUS Position: Q3 2026 in Review

UBS Group reduced its Nu Skin (NUS) stake by 83% in Q3 2026, selling an estimated $502K and leaving 20,945 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7201.

UBS Group first reported a position in NUS in Q4 2014 and has held it in 48 quarters since. The position peaked at $19M in Q4 2021. 98 funds tracked by Wall St. Rank hold NUS as of Q3 2026.

UBS Group held 20,945 shares of Nu Skin worth $94.9K as of Q3 2026.
UBS Group sold 101,684 Nu Skin shares in Q3 2026, an estimated $502K.
Nu Skin made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7201 holding.
UBS Group first reported a position in Nu Skin in Q4 2014 and has held it in 48 quarters since.
UBS Group's Nu Skin position peaked at $19M in Q4 2021.
98 funds tracked by Wall St. Rank held Nu Skin as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.